CELL INTELLIGENCE · 肿瘤细胞治疗研究

IL-15 超级激动剂用于重编程胃肠道腺癌的免疫抑制微环境

IL-15 superagonists for reprogramming the immunosuppressive microenvironment in gastrointestinal adenocarcinomas.

细胞毒性 T 淋巴细胞相关抗原-4（CTLA-4）在胃癌中的肿瘤表达

Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) tumour expression in gastric carcinoma.

HER2 作为前列腺癌的分子特洛伊木马：机制见解与治疗突破

HER2 as a molecular trojan horse in prostate cancer: mechanistic insights and therapeutic unlocks.

胃腺癌免疫治疗——快速演变的治疗格局

Immunotherapy in gastric adenocarcinoma - a rapidly evolving treatment landscape.

基于细胞因子的胃癌免疫治疗：靶向炎症以控制肿瘤

Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control.

创新免疫治疗及其对胃腺癌的变革性影响：对该疾病起源、流行病学、分类、诊断和治疗选择的综合综述

Innovative Immunotherapy and Its Transformative Impact on Gastric Adenocarcinoma: A Comprehensive Review of the Disease's Origins, Epidemiology, Class

三级淋巴结构和 B 细胞在胃癌临床免疫治疗中的作用

Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer.

利用转化平台开展胃肠道肿瘤新型疗法的综合综述

A Comprehensive Review on Novel Therapies for Gastrointestinal Cancers using Translational Platforms.

胃癌中的 TIL（肿瘤浸润淋巴细胞）：揭示复杂相互作用以实现精准医学

Tumor infiltrating lymphocytes in gastric cancer: Unraveling complex interactions for precision medicine.

用于 EBV 相关恶性肿瘤治疗的靶向裂解性 EBV 抗原 CAR-T 细胞的 GMP 开发与临床前验证

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies.

这些结果支持将用 ZT002 生成的 gp350CAR-T 细胞作为创新新药，用于治疗实体和血液 EBV 相关恶性肿瘤患者。